These findings highlight the impact of CRP on lung epithelial cells and may provide new insights into the mechanisms by which MP induces lung infection, suggesting potential therapeutic targets for treating MP-related respiratory infections. This evidence concerns the gene CRP and respiratory tract infectious disorder.